Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Combined Virtual Screening, MMPBSA, Molecular Docking And Dynamics Studies Against Deadly Anthrax: An In Silico Effort To Inhibit Bacillus Anthracis Nucleoside Hydrolase.

M. Karami, Chiya Jalali, S. Mirzaie
Published 2017 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Anthrax is a deadly disease caused by Bacillus anthracis, a dangerous biological warfare agent employed for both military and terrorist purposes. A critical selective target for chemotherapy against this disease is nucleoside hydrolase (NH), an enzyme still not found in mammals. In the current study, we have performed molecular docking and dynamics studies, aiming to propose the new potent inhibitors of B. anthracis NH among National Cancer Institute (NCI) Diversity Set. We also analyzed the principal interactions of proposed compounds with the active site residues of NH and the relevant factors to biological activity. Additionally, the physic-chemical properties of free and inhibitor bound NH were evaluated and discussed. Our data showed that compound NSC79887 is a good candidate to inhibit NH and also for biological tests and further development. Also, ADMET prediction revealed that all physic-chemical parameters are within the acceptable range defined for human use.
This paper references
10.1007/s00894-011-0968-9
Analysis of Bacillus anthracis nucleoside hydrolase via in silico docking with inhibitors and molecular dynamics simulation
A. P. Guimarães (2011)
10.1074/JBC.M111735200
Enzyme-Substrate Interactions in the Purine-specific Nucleoside Hydrolase from Trypanosoma vivax*
W. Versées (2002)
10.1016/J.EJMECH.2007.03.027
Synthesis and biochemical evaluation of guanidino-alkyl-ribitol derivatives as nucleoside hydrolase inhibitors.
A. Goeminne (2008)
10.1080/07391102.2010.10507330
Conformational Analysis of Genotoxic Benzo[a] pyrene-7,8-dione-Duplex DNA Adducts Using a Molecular Dynamics Method
B. Jin (2010)
10.1021/ci500020m
g_mmpbsa - A GROMACS Tool for High-Throughput MM-PBSA Calculations
R. Kumari (2014)
10.1371/journal.pcbi.1000634
Conformational Transitions upon Ligand Binding: Holo-Structure Prediction from Apo Conformations
D. Seeliger (2010)
10.1063/1.2408420
Canonical sampling through velocity rescaling.
G. Bussi (2007)
10.1021/BI00179A028
Amidrazone analogues of D-ribofuranose as transition-state inhibitors of nucleoside hydrolase.
M. Boutellier (1994)
10.1371/journal.pone.0141716
Structural and Enzymatic Characterization of a Nucleoside Diphosphate Sugar Hydrolase from Bdellovibrio bacteriovorus
Andres H. de la Peña (2015)
10.1080/07391102.2008.10507197
Conformational Characteristics of Unstructured Peptides: α-Synuclein
J. Yoon (2008)
10.1021/JM0208875
Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers.
A. Cavalli (2002)
10.1002/jcc.20035
Development and testing of a general amber force field
J. Wang (2004)
10.1080/07391102.2010.10507344
100 ns Molecular Dynamics Simulations to Study Intramolecular Conformational Changes in Bax
C. Koshy (2010)
10.18052/WWW.SCIPRESS.COM/ILNS.34.70
Virtual screening and docking studies of identified potential drug target: Polysaccharide deacetylase in Bacillus anthracis
Kunal Zaveri (2015)
10.21236/ada398241
Medical Aspects of Chemical and Biological Warfare
F. Sidell (1997)
10.1080/07391102.2011.10508589
Potent Inhibitor Design Against H1N1 Swine Influenza: Structure-based and Molecular Dynamics Analysis for M2 Inhibitors from Traditional Chinese Medicine Database
Chia-Hui Lin (2011)
10.1093/MILMED/160.8.369
From asps to allegations: biological warfare in history.
A. G. Robertson (1995)
10.1016/j.compbiomed.2011.12.009
Prediction of the mode of interaction between monoterpenes and the nitroreductase from Enterobacter cloacae by docking simulation
S. Mirzaie (2012)
10.1002/jcc.20291
GROMACS: Fast, flexible, and free
D. Spoel (2005)
10.1021/BI952998U
Inosine-uridine nucleoside hydrolase from Crithidia fasciculata. Genetic characterization, crystallization, and identification of histidine 241 as a catalytic site residue.
D. N. Gopaul (1996)
10.1016/j.str.2008.01.021
Multiple conformations of E. coli Hsp90 in solution: insights into the conformational dynamics of Hsp90.
K. Krukenberg (2008)
10.1023/A:1015040217741
Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs
J. Kelder (2004)
10.1023/A:1011930411574
Correlating Partitioning and Caco-2 Cell Permeability of Structurally Diverse Small Molecular Weight Compounds
M. Yazdanian (2004)
10.1080/07391102.2010.10507368
Influence of the Acetylcholinesterase Active Site Protonation on Omega Loop and Active Site Dynamics
J. Wiesner (2010)
10.1001/JAMA.287.17.2236
Anthrax as a biological weapon, 2002: updated recommendations for management.
T. Inglesby (2002)
10.1016/j.bmc.2008.05.056
N-Arylmethyl substituted iminoribitol derivatives as inhibitors of a purine specific nucleoside hydrolase.
A. Goeminne (2008)
10.1021/JA069124N
Structural characterization of flexible proteins using small-angle X-ray scattering.
P. Bernadó (2007)
10.1016/J.SNB.2007.11.036
Sensing NO2 with individual suspended single-walled carbon nanotubes
T. Helbling (2008)
10.1021/ci980411n
Prediction of the Brain-Blood Distribution of a Large Set of Drugs from Structurally Derived Descriptors Using Partial Least-Squares (PLS) Modeling
J. Luco (1999)
10.1016/J.JMGM.2005.12.005
Automatic atom type and bond type perception in molecular mechanical calculations.
J. Wang (2006)
10.1016/0166-6851(84)90117-8
Purine and pyrimidine metabolism in the Trypanosomatidae.
D. Hammond (1984)
10.1021/BI962319V
Isozyme-specific transition state inhibitors for the trypanosomal nucleoside hydrolases.
D. W. Parkin (1997)
10.1080/07391102.2010.10507365
Exposure of Hydrophobic Core in Human Prion Protein Pathogenic Mutant H187R
Linghao Zhong (2010)
10.1080/07391102.2009.10507292
A Docking Study Using Atomistic Conformers Generated via Elastic Network Model for Cyclosporin A/Cyclophilin A Complex
E. D. Akten (2009)
10.1080/07391102.2009.10507314
Simulation Studies on the Stabilities of Aggregates Formed by Fibril-Forming Segments of α-Synuclein
J. Yoon (2009)
10.1016/s0021-9258(18)54759-1
Nucleoside hydrolase from Crithidia fasciculata. Metabolic role, purification, specificity, and kinetic mechanism.
D. W. Parkin (1991)
10.1080/073911010010524952
Structural Model of the Pre-pore Ring-like Structure of Panton-Valentine Leukocidin: Providing Dimensionality to Biophysical and Mutational Data
M. Aman (2010)
10.1021/JA020312X
Computer simulations of trypanosomal nucleoside hydrolase: determination of the protonation state of the bound transition-state analogue.
Devleena Mazumder (2002)
10.1021/JA9621760
Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids
W. Jorgensen (1996)
10.1021/JM990017W
Designing libraries with CNS activity.
Ajay (1999)
10.1002/prot.22102
Very fast prediction and rationalization of pKa values for protein–ligand complexes
Delphine Bas (2008)
10.1080/07391102.2010.10507341
Structure-Based and Ligand-Based Drug Design for HER 2 Receptor
Hung-Jin Huang (2010)
10.1021/BI00089A007
Correlation of the molecular electrostatic potential surface of an enzymatic transition state with novel transition-state inhibitors.
B. Horenstein (1993)
10.1080/073911010010524953
Insight Derived from Molecular Dynamics Simulation into Substrate-Induced Changes in Protein Motions of Proteinase K
Y. Tao (2010)
10.1016/S0006-3495(00)76706-3
Induced fit in arginine kinase.
G. Zhou (2000)
A questão da defesa contra agentes de guerra biológica nas Forças Armadas e no Brasil
Tanos Celmar (2008)
10.1016/0040-4020(80)80168-2
ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES
J. Gasteiger (1980)
10.1002/jcc.21334
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
Oleg Trott (2010)
10.1021/LA00011A056
The origin of the hydration interaction of lipid bilayers from MD simulation of dipalmitoylphosphatidylcholine membranes in gel and liquid crystalline phases
U. Essmann (1995)
10.1080/07391102.2010.10507350
Molecular Dynamics Studies on Troponin (Tnl-TnT-TnC) Complexes: Insight into the Regulation of Muscle Contraction
Jayson F. Varughese (2010)
10.1080/07391102.2009.10507308
Computational Model of the HIV-1 Subtype A V3 Loop: Study on the Conformational Mobility for Structure-Based Anti-AIDS Drug Design
A. M. Andrianov (2009)
10.1080/07391102.2011.10508588
Design of New Chemotherapeutics Against the Deadly Anthrax Disease. Docking and Molecular Dynamics studies of Inhibitors Containing Pyrrolidine and Riboamidrazone Rings on Nucleoside Hydrolase from Bacillus anthracis
A. P. Guimarães (2011)
10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
LINCS: A linear constraint solver for molecular simulations
B. Hess (1997)
10.1080/07391102.2010.10507329
20ns Molecular Dynamics Simulation of the Antennapedia Homeodomain-DNA Complex: Water Interaction and DNA Structure Analysis
Sujata Roy (2010)
10.1016/j.jmb.2008.07.074
Integration of small-angle X-ray scattering data into structural modeling of proteins and their assemblies.
F. Förster (2008)
10.1080/07391102.2010.10508580
Molecular Dynamics Simulations of Cyclohexyl Modified Peptide Nucleic Acids (PNA)
S. Sharma (2010)
10.1016/J.SBI.2003.10.002
Catalysis by nucleoside hydrolases.
W. Versées (2003)
10.1016/0263-7855(96)00018-5
VMD: visual molecular dynamics.
W. Humphrey (1996)
10.1063/1.464397
Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems
T. Darden (1993)
10.1021/ci00052a002
The NCI Drug Information System. 1. System overview
G. Milne (1986)
10.1080/07391102.2009.10507259
Immunophilins and HIV-1 V3 Loop For Structure-Based Anti-AIDS Drug Design
A. M. Andrianov (2009)
10.3109/14756366.2015.1076811
Exploring the biological consequences of conformational changes in aspartame models containing constrained analogues of phenylalanine
A. Mollica (2016)
10.1063/1.328693
Polymorphic transitions in single crystals: A new molecular dynamics method
M. Parrinello (1981)
10.1021/BI00042A030
Binding modes for substrate and a proposed transition-state analogue of protozoan nucleoside hydrolase.
D. W. Parkin (1995)
10.1016/J.JMB.2006.03.026
Transition-state complex of the purine-specific nucleoside hydrolase of T. vivax: enzyme conformational changes and implications for catalysis.
W. Versées (2006)
10.1080/20508549.2003.11877665
Saint Leibowitz and Reflections on Bio-Chemical Warfare at the Beginning of the Twenty-First Century
R. E. Smith (2003)



This paper is referenced by
10.1093/ilar/ily021
Replacement, Refinement, and Reduction in Animal Studies With Biohazardous Agents.
L. Kendall (2019)
10.12991/JRP.2019.144
Vitamin D as a modulating agent of metformin and insulin in patients with type 2 diabetes
F. Abdi (2019)
10.2174/1386207322666191022142629
The effect of temperature on the interaction of phenanthroline-based ligands with G-quadruplex: In silico viewpoint.
Mohadeseh Bazoobandi (2019)
10.1080/08927022.2020.1726911
Novel potential inhibitor discovery against tyrosyl-tRNA synthetase from Staphylococcus aureus by virtual screening, molecular dynamics, MMPBSA and QMMM simulations
Chiako Farshadfar (2020)
10.26434/chemrxiv.11875446.v1
Fast Identification of Possible Drug Treatment of Coronavirus Disease -19 (COVID-19) Through Computational Drug Repurposing Study.
J. Wang (2020)
10.1007/s00253-018-9529-9
Engineering an efficient mutant of Eupenicillium terrenum fructosyl peptide oxidase for the specific determination of hemoglobin A1c
Hamid Shahbazmohammadi (2018)
10.1007/s13721-020-00244-9
Structure-based virtual screening, molecular docking and dynamics studies of natural product and classical inhibitors against human dihydrofolate reductase
E. Koushki (2020)
10.1080/07391102.2020.1751713
Molecular docking and molecular dynamics simulations studies on β-glucosidase and xylanase Trichoderma asperellum to predict degradation order of cellulosic components in oil palm leaves for nanocellulose preparation.
Aina Hazimah Bahaman (2020)
10.1016/j.mehy.2018.01.004
Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM studies.
Noeman Ardalan (2018)
10.1039/c8cp06776g
Molecular mechanism and binding free energy of doxorubicin intercalation in DNA.
Bahaa Jawad (2019)
10.3389/fimmu.2019.00813
Nucleoside Hydrolase NH 36: A Vital Enzyme for the Leishmania Genus in the Development of T-Cell Epitope Cross-Protective Vaccines
C. B. Palatnik-de-Sousa (2019)
10.1021/acs.jcim.0c00179
Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study
J. Wang (2020)
10.1007/s00894-018-3858-6
In silico assessment of new progesterone receptor inhibitors using molecular dynamics: a new insight into breast cancer treatment
V. Zarezade (2018)
10.1016/j.compbiolchem.2018.08.005
Identification of novel inhibitor against endonuclease subunit of Influenza pH1N1 polymerase: A combined molecular docking, molecular dynamics, MMPBSA, QMMM and ADME studies to combat influenza A viruses
Seyed Sajad Mohseni (2018)
10.1039/d0cp02459g
Destabilization potential of phenolics on Aβ fibrils: mechanistic insights from molecular dynamics simulation.
Shivani Gupta (2020)
10.1016/j.jmgm.2017.10.013
Effects of synergistic and non-synergistic anions on the iron binding site from serum transferrin: A molecular dynamic simulation analysis.
Z. Ghanbari (2017)
Semantic Scholar Logo Some data provided by SemanticScholar